493 followers
Progression-free surv at 2y as a surrogate marker for the 5y surv rate in advanced NSCLC treated with ChRT http://t.co/JiqvTI2oIV #bmccancer
Progression-free surv at 2y as a surrogate marker for the 5y surv rate in advanced NSCLC treated with ChRT http://t.co/JiqvTI2oIV #bmccancer
Progression-free surv at 2y as a surrogate marker for the 5y surv rate in advanced NSCLC treated with ChRT http://t.co/JiqvTI2oIV #bmccancer